Company Filing History:
Years Active: 1997
Title: John K Whisnant: Innovator in Asthma Treatment
Introduction
John K Whisnant is a notable inventor based in Ft. Lauderdale, FL (US). He has made significant contributions to the field of medicine, particularly in the treatment of asthma. His innovative approach has the potential to improve the quality of life for many patients suffering from this condition.
Latest Patents
Whisnant holds a patent for a method of treating asthma. This method involves intrabronchial administration of a pharmaceutical composition containing ultra-low molecular weight heparins (ULMWH). The treatment is designed for patients suffering from antigen-induced asthma, aiming to reduce airway hyperresponsiveness. The patent details the administration of about 0.05 to about 1.0 mg of ULMWH per kilogram of patient body weight, providing a novel approach to asthma management.
Career Highlights
John K Whisnant is associated with Baker Norton Pharmaceuticals, Inc., where he continues to work on innovative solutions for asthma treatment. His dedication to research and development has positioned him as a key figure in the pharmaceutical industry.
Collaborations
Whisnant has collaborated with notable professionals in his field, including Tahir Ahmed and Samuel Broder. These partnerships have contributed to the advancement of his research and the development of effective treatments.
Conclusion
John K Whisnant's work in asthma treatment exemplifies the impact of innovation in healthcare. His patented method offers hope for improved management of asthma, showcasing the importance of continued research and collaboration in the medical field.